根据内镜诊断,组织病理学和粘膜炎症媒介的结肠炎的粘膜治疗
Kazuhiko Uchiyama1, Tomohisa Takagi1,2, Eiki Murakami1
1Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
精确诊断性结肠炎 (UC) 粘膜愈合对于长期缓解至关重要. 本综述探讨了粘膜基因表达作为一种新的诊断方法,补充了内镜和组织学评估,以更好地管理UC.
科学领域:
- 胃肠病学 胃肠病学
- 分子生物学分子生物学
- 医学诊断 医学诊断 医学诊断
背景情况:
- 粘膜愈合对于性结肠炎 (UC) 缓解至关重要,内镜评估 (梅奥内镜子评分) 是标准的.
- 尽管内镜治疗 (MES 0),UC复发可能会发生,突出现有方法的局限性.
- 图像增强内镜和组织学评分系统 (Geboes,Nancy,Robarts) 改善了复发预测,但存在局限性.
研究的目的:
- 从粘膜基因表达的角度审查UC中的粘膜愈合.
- 为了突出基于细胞因子配置文件的"分子治疗"的新兴概念.
- 强调需要准确诊断粘膜愈合,以有效管理UC.
主要方法:
- 对UC粘膜愈合的内镜和组织学评估当前文献的综述.
- 讨论细胞因子在UC病变发生中的作用及其与愈合的相关性.
- 探索粘膜基因表达作为潜在的诊断标记.
主要成果:
- 细胞因子表达与内镜严重程度相关,并预测UC复发.
- 粘膜基因表达为了解和诊断UC愈合提供了一个新的维度.
- 由细胞因子配置文件定义的分子治疗是一种新兴的诊断范式.
结论:
- 准确诊断UC的粘膜愈合对于预测复发和指导治疗至关重要.
- 粘膜基因表达分析代表了UC的有希望的下一代诊断方法.
- 整合分子,组织学和内镜数据将优化对UC的粘膜愈合的评估.
更多相关视频
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
09:42Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
